PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22189943-4	2012	Treatment of HUVEC with UA and a calcium mobilization inhibitor (TMB-8) or a MEK/Erk pathway inhibitor (U0126) prevented translocation of HMGB1 from the nucleus, resulting in reduced cytoplasmic and circulating levels of HMGB1.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	65-70	high mobility group box 1	Homo sapiens	138-143	
22189943-4	2012	Treatment of HUVEC with UA and a calcium mobilization inhibitor (TMB-8) or a MEK/Erk pathway inhibitor (U0126) prevented translocation of HMGB1 from the nucleus, resulting in reduced cytoplasmic and circulating levels of HMGB1.	8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate	65-70	high mobility group box 1	Homo sapiens	221-226